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ABSTRACT 
 
Background: Diabetes mellitus is one of the leading causes of morbidity and mortality because of its role in the 
development of optic, renal, neuropathic and cardiovascular diseases (CVD). It is major public health care problem 
in developed countries as well as developing areas like India. Objectives: The aim of this study is to determine the 
serum high sensitive C- Reactive Protein (hs-CRP) and urinary microalbumin levels in patients with type 2 diabetes 
mellitus and to compare with healthy controls. Materials and Methods: In this study total 80 subjects were 
included above 40 years of age. 40 clinically diagnosed type 2 diabetic patients and 40 normal subjects were 
recruited as control. Microalbumin and hs-CRP were measured by latex turbidimetric method. Statistical Analysis: 
Data were analyzed using student ‘t’ test for their level of significance. Results:  The mean microalbumin level in 
type 2 diabetic patients was significantly higher than in the controls. The serum hs-CRP levels were significantly 
higher in patients as compared to control subjects. Conclusion: Increased levels of hs-CRP and microalbumin may 
be implicated in the development of cardiovascular disease and renal impairment and these investigations will 
defiantly help in the management of diabetic patients.  
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Introduction 
 
Diabetes is now among the five leading causes of death 
due to disease in most countries. [1] Approximately 171 
to 194 million people in the world have diabetes. This 
number is expected to increase to more than 300 million 
by the year 2025 – a doubling within a single generation. 
It is major public health care problem in developed 
countries as well as developing areas like India. [2, 
3]Type 2 diabetes is a multifactorial disease and shows 
heterogeneity in numerous respects. [4] As the 
prevalence of type 2 diabetes increases, the disease is 
encroaching on younger and younger adults. [5] This 
decline in the age of onset of type 2 diabetes is an 
important factor influencing the future burden of the 
disease. 
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Since onset in childhood heralds many years of disease 
and an accumulation of the full gamut of complications. 
Type 2 diabetes in children and adolescents has now 
become a major new challenge in diabetes. [6] Type 2 
diabetes frequently goes undiagnosed for many years 
because the hyperglycemia develops gradually and in the 
earlier stages is not severe enough to produce the classic 
symptoms of diabetes; however such patients are at 
increased risk of developing macrovascular and 
microvascular complications.[7]The manifestations 
include the metabolic syndrome, a cluster of 
cardiovascular disease (CVD) risk factors, which apart 
from glucose intolerance include hyperinsulinemia, 
dyslipidemia, hypertension, visceral obesity, 
hypercoagulability and microalbuminuria.[1]One 
common and extremely serious complication of diabetes 
is kidney disease. Early detection of microalbumin is 
important because it indicates increased risk for both 
renal and vascular disease. It is a marker of early diabetic 
nephropathy, CVD and hypertension. [8] The CVD are 
seen to develop in type 2 diabetic patients and this may 
be associated with elevated inflammatory markers. 
High sensitive C - reactive protein (Hs-CRP) is 
considered as a systemic inflammatory marker which 
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shows marked increase in conformation to acute 
inflammation, infection and tissue injury. Hence hs-CRP 
can be considered as a good marker for inflammation 
which plays a role in the initiation and progression of 
CVD. [9]Therefore, the present study was planned in 
measure the biochemical parameters relevant to 
development of CVD and Kidney diseases i.e. 
microalbumin in urine and serum hs-CRP in type 2 
diabetics. 
 
Materials and Methods 
 
Present study was conducted in the Department of 
Biochemistry, Government Medical College, Miraj. 
Study group included 40 patients above 40 years of age 
and diagnosed by clinicians as type 2 diabetes mellitus 
based on performing fasting blood glucose and 
glycosylated hemoglobin determinations. Control group 
included 40 health controls without any family history of 
diabetes and no abnormal clinical findings and matching 
in age with study group.The institutional Ethics 
Committee approved the study and consent was obtained 
from each participant in the study. Patients with 
myocardial infarction, renal diseases, coronary heart 
disease and type 1 diabetes mellitus were excluded from 
this study.Blood samples were collected from control 
group and study group under aseptic conditions. The first 
morning urine was also collected for the determination of 
microalbumin The urinary microalbumin was determined 
immediately by latex turbidimetric method. [10] Sera 
samples were preserved at -20°C before hs-CRP 
estimation by latex turbidimetric method. [11]Statistical 
analysis was performed using Minitab software.  
 
Results and discussion 
 
The albumin excretion in the urine between 30 to 300 
mg/day is known as microalbuminuria. [12] We found 
that, out of 40 diabetic patients 34 patients (84%) had 
microalbuminuria whereas 100% of control group were 
non-microalbuminuric. In the present study 
microalbumin was also quantified and the mean 
microalbumin level was significantly higher in diabetic 
patients as compared to that of controls (Table 1, P< 
0.001). A severe and sustained inflammatory reaction 
induces rapid and profound changes in the endothelium 
resulting in loss of barrier integrity leading to systemic 
capillary leak. [13, 14] This manifests as altered 
glomerular permeability culminating in increased renal 
albumin excretion in the urine. This is important 
indicator of deteriorating renal function. Impairment of 
renal function is a common microvascular complication 
of diabetes. [15]In our study, the mean serum hs-CRP 
level was significantly higher in type 2 diabetic patients 
as compared to controls (Table 1, P<0.001). The hs-CRP 
method is to detect low concentration of CRP in serum 
required for the prediction of inflammation. 
Inflammation is evident from the accumulation of 
monocytes and macrophages at the site of plaque 
rupture.Remarkable increase in serum CRP level may 
reflect the development and progression of 
atherosclerosis. Inflammation has a causal role in the 
development of diabetes also; thus the requirement of 
CRP by high sensitive assays can be used to predict the 
risk of diabetic complications like cardiovascular and 
peripheral vascular diseases. [16]Mechanism involved in 
the alteration of hs-CRP and microalbumin may be 
complicated and independent of each other. Hence we 
observed no significant correlation between hs-CRP and 
microalbumin concentration, although both the 
parameters are raised in diabetes.To conclude, the 
microalbuminuria is associated with progression of 
chronic kidney disease and the development of 
cardiovascular morbidity and mortality. Serum hs-CRP 
is an exquisitely sensitive systemic marker of 
inflammation.Hence measurement of urinary micro 
albumin and serum       hs-CRP in risk group can help the 
physician in better management of type 2 diabetic 
patients.     
 
Table No. 1: High sensitive C-reactive protein (hs-CRP) and microalbumin levels in diabetic patients and 
controls 
 
Subjects 
 
 HS-CRP (mg/L/) (Mean ± SD) 
 
Microalbumin (mg/L) Mean ± SD 
 
 
Patients 
 
 
7.02 ± 3.94* 
 
37.7 ± 17.9* 
Controls 
 
                     1.78 ± 1.68                         9.97 ± 5.82 
 
The statistical method used to compare data was ‘ t ’ test.*P< 0.001, highly significant.   
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